These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26010128)

  • 21. Evaluation of Left Ventricular Outflow Gradients During Staged Exercise Stress Echocardiography Helps Differentiate Pediatric Patients With Hypertrophic Cardiomyopathy From Athletes and Normal Subjects.
    Gaitonde M; Jones S; McCracken C; Ferguson ME; Michelfelder E; Sachdeva R; Border W
    Pediatr Exerc Sci; 2021 Jul; 33(4):196-202. PubMed ID: 34303306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise modulates circulating adipokine levels in hypertrophic cardiomyopathy.
    Dimitrow PP; Undas A; Cheng TO
    Pol Arch Med Wewn; 2011 Nov; 121(11):384-90. PubMed ID: 22129834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between outflow obstruction and left ventricular functional impairment in hypertrophic cardiomyopathy: a Doppler echocardiographic study.
    Araujo AQ; Arteaga E; Ianni BM; Fernandes F; Ramires FJ; Buck PC; Salemi VM; Nastari L; Mady C
    Echocardiography; 2006 Oct; 23(9):734-40. PubMed ID: 16999691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy.
    Geske JB; Sorajja P; Ommen SR; Nishimura RA
    JACC Cardiovasc Interv; 2011 Jun; 4(6):704-9. PubMed ID: 21700258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging.
    Kwon DH; Smedira NG; Popovic ZB; Lytle BW; Setser RM; Thamilarasan M; Schoenhagen P; Flamm SD; Lever HM; Desai MY
    Heart; 2009 Nov; 95(21):1784-91. PubMed ID: 19549621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy.
    Stern JA; Markova S; Ueda Y; Kim JB; Pascoe PJ; Evanchik MJ; Green EM; Harris SP
    PLoS One; 2016; 11(12):e0168407. PubMed ID: 27973580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype.
    Güçlü A; Happé C; Eren S; Korkmaz IH; Niessen HW; Klein P; van Slegtenhorst M; Schinkel AF; Michels M; van Rossum AC; Germans T; van der Velden J
    Eur J Clin Invest; 2015 Dec; 45(12):1252-9. PubMed ID: 26444145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marked respiratory-related fluctuations in left ventricular outflow tract gradients in hypertrophic obstructive cardiomyopathy: an observational study.
    Jain R; Osranek M; Jan MF; Kalvin LR; Olet S; Allaqaband SQ; Jahangir A; Khandheria BK; Tajik AJ
    Eur Heart J Cardiovasc Imaging; 2018 Oct; 19(10):1126-1133. PubMed ID: 28950345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
    Menon SC; Ackerman MJ; Ommen SR; Cabalka AK; Hagler DJ; O'Leary PW; Dearani JA; Cetta F; Eidem BW
    J Am Soc Echocardiogr; 2008 Jun; 21(6):684-8. PubMed ID: 18187287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aortic stiffness independently predicts exercise capacity in hypertrophic cardiomyopathy: a multimodality imaging study.
    Austin BA; Popovic ZB; Kwon DH; Thamilarasan M; Boonyasirinant T; Flamm SD; Lever HM; Desai MY
    Heart; 2010 Aug; 96(16):1303-10. PubMed ID: 20659950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Kwon DH; Setser RM; Thamilarasan M; Popovic ZV; Smedira NG; Schoenhagen P; Garcia MJ; Lever HM; Desai MY
    Heart; 2008 Oct; 94(10):1295-301. PubMed ID: 17690158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography.
    Masri A; Pierson LM; Smedira NG; Agarwal S; Lytle BW; Naji P; Thamilarasan M; Lever HM; Cho LS; Desai MY
    Am Heart J; 2015 May; 169(5):684-692.e1. PubMed ID: 25965716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve.
    Ro R; Halpern D; Sahn DJ; Homel P; Arabadjian M; Lopresto C; Sherrid MV
    J Am Coll Cardiol; 2014 Nov; 64(19):1984-95. PubMed ID: 25440093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy.
    Zemánek D; Tomasov P; Homolová S; Linhartová K; Veselka J
    Eur J Echocardiogr; 2011 Sep; 12(9):684-7. PubMed ID: 21821607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study.
    Sorajja P; Nishimura RA; Gersh BJ; Dearani JA; Hodge DO; Wiste HJ; Ommen SR
    J Am Coll Cardiol; 2009 Jul; 54(3):234-41. PubMed ID: 19589436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the best surgical treatment for obstructive hypertrophic cardiomyopathy and degenerative mitral regurgitation?
    Wan CK; Dearani JA; Sundt TM; Ommen SR; Schaff HV
    Ann Thorac Surg; 2009 Sep; 88(3):727-31; discussion 731-2. PubMed ID: 19699887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Left intraventricular gradients measured by Doppler echocardiography at rest, during exercise and during isoproterenol test in hypertrophic cardiomyopathy].
    Decoulx E; Goullard L; Millaire A; Lecroart JL; de Groote P; Houdas Y; Ducloux G
    Arch Mal Coeur Vaiss; 1992 Jun; 85(6):839-45. PubMed ID: 1417402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertrophic cardiomyopathy with right ventricular outflow tract and left ventricular intracavitary obstruction.
    Malik R; Maron MS; Rastegar H; Pandian NG
    Echocardiography; 2014 May; 31(5):682-5. PubMed ID: 24649889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.